Related references
Note: Only part of the references are listed.mRNA Vaccines in the COVID-19 Pandemic and Beyond
Michael J. Hogan et al.
ANNUAL REVIEW OF MEDICINE (2022)
Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses
Norbert Pardi et al.
NATURE COMMUNICATIONS (2022)
A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial
Raffael Nachbagauer et al.
NATURE MEDICINE (2021)
mRNA vaccination induces tick resistance and prevents transmission of the Lyme disease agent
Andaleeb Sajid et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Antigen modifications improve nucleoside-modified mRNA-based influenza virus vaccines in mice
Alec W. Freyn et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2021)
A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice
Alec W. Freyn et al.
MOLECULAR THERAPY (2020)
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice
Dorottya Laczko et al.
IMMUNITY (2020)
Dynamic Natural Killer Cell and T Cell Responses to Influenza Infection
Kayla Frank et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccine
Philip C. LaTourette et al.
VACCINE (2020)
Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages
Kizzmekia S. Corbett et al.
MBIO (2019)
A Facile Method for the Removal of dsRNA Contaminant from In Vitro-Transcribed mRNA
Markus Baiersdoerfer et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice
Guha Asthagiri Arunkumar et al.
VACCINE (2019)
Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge
Meagan McMahon et al.
FRONTIERS IN IMMUNOLOGY (2019)
The neuraminidase of A(H3N2) influenza viruses circulating since 2016 is antigenically distinct from the A/Hong Kong/4801/2014 vaccine strain
Hongquan Wan et al.
NATURE MICROBIOLOGY (2019)
Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes
Sita Awasthi et al.
SCIENCE IMMUNOLOGY (2019)
Broadly protective human antibodies that target the active site of influenza virus neuraminidase
Daniel Stadlbauer et al.
SCIENCE (2019)
Cross-reactive antibodies binding to H4 hemagglutinin protect against a lethal H4N6 influenza virus challenge in the mouse model
Fatima Amanat et al.
EMERGING MICROBES & INFECTIONS (2019)
Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses
Norbert Pardi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity
Shinu John et al.
VACCINE (2018)
Use of Hemagglutinin Stem Probes Demonstrate Prevalence of Broadly Reactive Group 1 Influenza Antibodies in Human Sera
Hadi M. Yassine et al.
SCIENTIFIC REPORTS (2018)
Heterologous Two-Dose Vaccination with Simian Adenovirus and Poxvirus Vectors Elicits Long-Lasting Cellular Immunity to Influenza Virus A in Healthy Adults
L. Coughlan et al.
EBIOMEDICINE (2018)
A Live-Attenuated Prime, Inactivated Boost Vaccination Strategy with Chimeric Hemagglutinin-Based Universal Influenza Virus Vaccines Provides Protection in Ferrets: A Confirmatory Study
Raffael Nachbagauer et al.
VACCINES (2018)
Pathogenicity testing of influenza candidate vaccine viruses in the ferret model
Jessica A. Belser et al.
VIROLOGY (2017)
Universal influenza virus vaccines and therapeutic antibodies
R. Nachbagauer et al.
CLINICAL MICROBIOLOGY AND INFECTION (2017)
Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategies
Michael Schotsaert et al.
SCIENTIFIC REPORTS (2016)
Novel universal influenza virus vaccine approaches
Florian Krammer
CURRENT OPINION IN VIROLOGY (2016)
Advances in the development of influenza virus vaccines
Florian Krammer et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Vaccination with Adjuvanted Recombinant Neuraminidase Induces Broad Heterologous, but Not Heterosubtypic, Cross-Protection against Influenza Virus Infection in Mice
Teddy John Wohlbold et al.
MBIO (2015)
H3N2 Mismatch of 2014-15 Northern Hemisphere Influenza Vaccines and Head-to-head Comparison between Human and Ferret Antisera derived Antigenic Maps
Hang Xie et al.
SCIENTIFIC REPORTS (2015)
H3 Stalk-Based Chimeric Hemagglutinin Influenza Virus Constructs Protect Mice from H7N9 Challenge
Florian Krammer et al.
JOURNAL OF VIROLOGY (2014)
Assessment of Influenza Virus Hemagglutinin Stalk-Based Immunity in Ferrets
Florian Krammer et al.
JOURNAL OF VIROLOGY (2014)
The M Segment of the 2009 Pandemic Influenza Virus Confers Increased Neuraminidase Activity, Filamentous Morphology, and Efficient Contact Transmissibility to A/Puerto Rico/8/1934-Based Reassortant Viruses
Patricia J. Campbell et al.
JOURNAL OF VIROLOGY (2014)
In the Shadow of Hemagglutinin: A Growing Interest in Influenza Viral Neuraminidase and Its Role as a Vaccine Antigen
Teddy John Wohlbold et al.
VIRUSES-BASEL (2014)
H3N2 Influenza Virus Infection Induces Broadly Reactive Hemagglutinin Stalk Antibodies in Humans and Mice
Irina Margine et al.
JOURNAL OF VIROLOGY (2013)
Hemagglutinin Stalk-Based Universal Vaccine Constructs Protect against Group 2 Influenza A Viruses
I. Margine et al.
JOURNAL OF VIROLOGY (2013)
Chimeric Hemagglutinin Influenza Virus Vaccine Constructs Elicit Broadly Protective Stalk-Specific Antibodies
Florian Krammer et al.
JOURNAL OF VIROLOGY (2013)
Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics
Martin A. Maier et al.
MOLECULAR THERAPY (2013)
Genome-wide mutagenesis of influenza virus reveals unique plasticity of the hemagglutinin and NS1 proteins
Nicholas S. Heaton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
A Carboxy-Terminal Trimerization Domain Stabilizes Conformational Epitopes on the Stalk Domain of Soluble Recombinant Hemagglutinin Substrates
Florian Krammer et al.
PLOS ONE (2012)
Highly Conserved Protective Epitopes on Influenza B Viruses
Cyrille Dreyfus et al.
SCIENCE (2012)
Protection against a lethal H5N1 influenza challenge by intranasal immunization with virus-like particles containing 2009 pandemic H1N1 neuraminidase in mice
Judith D. Easterbrook et al.
VIROLOGY (2012)
Potent CD8(+) T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA-NP+M1
Tamara K. Berthoud et al.
CLINICAL INFECTIOUS DISEASES (2011)
Attenuated Strains of Influenza A Viruses Do Not Induce Degradation of RNA Polymerase II
Ariel Rodriguez et al.
JOURNAL OF VIROLOGY (2009)
Universal influenza A vaccine: Optimization of M2-based constructs
M De Filette et al.
VIROLOGY (2005)
Safety evaluation in chickens of candidate human vaccines against potential pandemic strains of influenza
Y Matsouka et al.
AVIAN DISEASES (2003)
Share Paper
